Modifications of Apoprotein, Lipoprotein Parameters and HDL2 and HDL3 Subfractions During Treatment with Bezafibrate Retard

Drugs Affecting Lipid Metabolism - Proceedings in Life Sciences ◽

10.1007/978-3-642-71702-4_54 ◽

1987 ◽

pp. 291-294

Author(s):

A. Ventura ◽

E. Mannarino ◽

G. Ciuffetti ◽

D. Siepi ◽

G. Lupattelli

Download Full-text